Rodney S. Markin, Director at Trovagene, Inc. (TROV), bought 41,200 shares at $0.85 ($35K) on 2018-06-20, disclosed to the SEC on 2018-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |